Clinical Trials Logo

Cannabis Use Disorder, Mild clinical trials

View clinical trials related to Cannabis Use Disorder, Mild.

Filter by:
  • None
  • Page 1

NCT ID: NCT05064319 Recruiting - Bipolar Disorder Clinical Trials

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders

Start date: February 24, 2022
Phase: Phase 2
Study type: Interventional

This research study evaluates the effects of an FDA-approved medication Gabapentin in individuals with Bipolar Disorder who smoke marijuana. Participants in the study will will be assigned to take either Gabapentin or a matched placebo. Study medication will be taken for 17 days. There will be 5 study visits, with 2 MRI brain imaging scans completed. Questionnaires and clinical interview measures will be completed at study visits along with consistent assessment of potential side effects from study medication.

NCT ID: NCT04964739 Recruiting - Clinical trials for Cannabis Use Disorder, Moderate

Gender/Sex & CUD Remission

Start date: November 15, 2021
Phase: N/A
Study type: Interventional

Adults (ages 18+) who would like to reduce their cannabis use (N=224) will be enrolled in an 8-week treatment program. All participants will receive counseling (1 goals session with a therapist followed by 7 weekly computerized cognitive-behavioral therapy sessions). Detailed cannabis assessments (biological and self-report) will be conducted throughout treatment and at 1-, 2-, and 3-months post-treatment completion. Daily electronic diaries will be administered via text message to record detailed logs of cannabis use quantity and frequency. Salivary samples will be collected (and video observed) daily throughout treatment to analyze for progesterone.

NCT ID: NCT04923230 Completed - Clinical trials for Cannabis Use Disorder, Moderate

Pilot Test of Parent-Focused Cannabis-Related Actions and Practices Intervention for Adolescent Marijuana Abuse

CAP
Start date: June 1, 2021
Phase: N/A
Study type: Interventional

The randomized clinical trial involves the pilot-testing of a theory-guided, empirically based, and low-cost intervention designed for legal medical marijuana-using parents to enhance parenting behaviors that limit youth exposure to marijuana, reduce or halt youth marijuana use, and increase youth awareness of the harmful consequences of marijuana during the youth years. Parents will be randomized to an intervention condition or to a wait list control condition. Pre- and post-intervention assessments will evaluate parent and youth marijuana and other substance use, perceptions and attitudes about marijuana, parenting and family functioning, and youth behavioral health.

NCT ID: NCT04567394 Active, not recruiting - Clinical trials for Cannabis Use Disorder, Moderate

Cannabis Use Disorder Treatment Study

Start date: December 7, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test a text-delivered counseling program to stop or reduce cannabis use among young adults (ages 18 to 25).